Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Sex Transm Dis. 2021 May 1;48(5):370–380. doi: 10.1097/OLQ.0000000000001327

Table 1.

Genotype groupings for the different patient management strategies

Group A Group B Group C
Patient Management Strategy 1 16, 18 31, 45, 33/58, 51, 52, 35/39/68 56/59/66
Patient Management Strategy 2 16, 18 31, 45, 33/58, 52 51, 35/39/68, 56/59/66
Patient Management Strategy 3 16, 18 31, 45, 33/58 51, 52, 35/39/68, 56/59/66

Group A patients undergo immediate colposcopy

Group B patients with any abnormal cytology results will go to colposcopy

Group C patients with atypical glandular cells (AGC), atypical squamous cells: cannot exclude high-grade squamous intraepithelial lesion (ASC-H), or a high-grade squamous intraepithelial lesion (HSIL) on cytology will go to colposcopy